Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
DescriptionInvestment Firm




Baxter Ventures

Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. Our focus includes therapeutic areas complementary to those of Baxter’s Medical Products and BioScience businesses, as well as cutting-edge technologies and therapies outside of our current product portfolio that have sustainable long-term growth potential.

As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to develop products and therapies that advance patient care worldwide.

Recent Milestones


Company Date Round Size Participants
Covagen 2/2014Series B$2.81M1
Covagen 12/2013Series B$47.2M8
Regado Biosciences 12/2012Series E$51M8



  1. Covagen Raises Additional CHF2.5M in Series B Round ( [edit]
  2. Gimv leads Series B round for Covagen ( [edit]
  3. Regado Biosciences, Inc. Secures $51 Million Series E Financing ( [edit]
Edit This Page
Last Edited 4/11/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy